Acute chest pain (ACP) is a common yet challenging symptom presenting in clinical practice. It can signify a range of conditions from benign to life-threatening. Thus, a systematic diagnostic approach is crucial to manage patients effectively and efficiently.
The initial assessment is a critical step in evaluating patients with ACP. A thorough history, physical examination, and 12-lead electrocardiogram (ECG) are vital to identify potential cardiac causes. The clinician must consider the character, onset, location, duration, and radiation of pain, along with associated symptoms.
Risk stratification using tools such as the HEART score can guide further management. It includes five elements: History, ECG, Age, Risk factors, and Troponin level. Patients are categorized into low, intermediate, or high-risk groups, determining the need for hospital admission or outpatient management.
While acute coronary syndrome (ACS) is a crucial differential, other life-threatening conditions such as pulmonary embolism, aortic dissection, and pneumothorax must be considered. Non-cardiac causes like gastroesophageal reflux disease (GERD) and musculoskeletal pain are also common.
Diagnostic testing should be tailored to the individual patient. High-sensitivity troponin assays have improved the early detection of ACS. Additionally, imaging modalities like coronary computed tomography angiography (CCTA) can provide further diagnostic clarity.
Deciphering the cause of ACP requires a systematic, patient-centered approach. It involves a comprehensive initial assessment, risk stratification, consideration of a broad differential diagnosis, and judicious use of diagnostic testing. This approach ensures optimal patient outcomes while minimizing unnecessary investigations and hospital admissions.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation